EditorialFormula-based dosing for carboplatin
References (16)
- et al.
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
Eur. J. Cancer
(1999) - et al.
Carboplatin dosageprospective evaluation of a simple formula based on renal function
J. Clin. Oncol.
(1989) - et al.
Prediction of carboplatin clearance from standard morphological and biological patient characteristics
J. Natl. Cancer Inst.
(1995) - et al.
Relationships between carboplatin exposure and tumour response and toxicity in patients with ovarian cancer
J. Clin. Oncol.
(1992) - et al.
A randomised trial of high versus standard dose carboplatin in patients with advanced epithelial ovarian cancer
Proc. Am. Soc. Clin. Oncol.
(1996) - et al.
Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer
J Clin Oncol
(1993) - et al.
Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum (II) analogue diamminecyclobutanedicarboxylatoplatinum
Cancer Res.
(1985) A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel
Semin. in Oncology
(1997)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1999 Elsevier Science Ltd. All rights reserved.